CWVGX
Price
$26.06
Change
+$0.08 (+0.31%)
Updated
Oct 20 closing price
Net Assets
893.25M
RERFX
Price
$66.21
Change
+$0.86 (+1.32%)
Updated
Oct 20 closing price
Net Assets
137.06B
Interact to see
Advertisement

CWVGX vs RERFX

Header iconCWVGX vs RERFX Comparison
Open Charts CWVGX vs RERFXBanner chart's image
Calvert International Equity A
Price$26.06
Change+$0.08 (+0.31%)
VolumeN/A
Net Assets893.25M
American Funds EUPAC R5
Price$66.21
Change+$0.86 (+1.32%)
VolumeN/A
Net Assets137.06B
CWVGX vs RERFX Comparison Chart in %
View a ticker or compare two or three
VS
CWVGX vs. RERFX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWVGX is a Hold and RERFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 137B vs. CWVGX (893M). CWVGX pays higher dividends than RERFX: CWVGX (1.03) vs RERFX (0.85). CWVGX was incepted earlier than RERFX: CWVGX (33 years) vs RERFX (23 years). CWVGX (1.20) is less costly to investors than RERFX (0.52). RERFX is a more actively managed with annual turnover of: 35.00 vs. CWVGX (23.00). RERFX has a lower initial minimum investment than CWVGX: RERFX (250) vs CWVGX (1000). RERFX annual gain was more profitable for investors over the last year : 11.45 vs. CWVGX (8.93). CWVGX return over 5 years is better than : 30.90 vs. RERFX (15.27).
CWVGXRERFXCWVGX / RERFX
Total Expense Ratio1.140.52219%
Annual Report Gross Expense Ratio1.200.52231%
Fund Existence33 years23 years-
Gain YTD17.59921.78581%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets893M137B1%
Annual Yield % from dividends1.030.85120%
Returns for 1 year8.9311.4578%
Returns for 3 years52.1249.90104%
Returns for 5 years30.9015.27202%
Returns for 10 years71.0944.43160%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WAL72.482.16
+3.07%
Western Alliance Bancorporation
EFSCP20.040.19
+0.96%
Enterprise Financial Services Corp
ANNX3.15-0.02
-0.63%
Annexon
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
AMLX14.95-0.22
-1.45%
Amylyx Pharmaceuticals